Patient Search
 |
 |
|
KaCrole Higgins was diagnosed with breast cancer in 2020. “In May 2020, I found a lump in my breast. I cried. By June, it was diagnosed as breast cancer, triple positive, stage 1A. While getting this cancer diagnosis was devastating, it also became an opportunity. Suddenly, the cancer gave me clarity. It gave me clarity about what was important, what was good in my life, what was toxic in my life, and what I needed to do.” Click below to read more of KaCrole’s story |
If Landon Ryan had been diagnosed with bilateral retinoblastoma 10, 20 or 30 years ago, she might not be here today with nearly perfect vision.Thanks to recent improvements in the treatment for this rare form of cancer that almost exclusively affects children under the age of 5, the diagnosis had the power to change Landon’s life when she was 11 months old, but not to take it — or her eyesight. Click below to learn more about Landon and her story. https://momentum.vicc.org/2022/04/brighter-outlook/ |
A Phase 3, Randomized, Open-Label, Multicenter Study of Sacituzumab Tirumotecan (sac-TMT, MK-2870) Maintenance Treatment with or without Bevacizumab versus Standard of Care in Participants with Newly Diagnosed Advanced Non-HRD-Positive Ovarian Cancer Following First-Line Platinum-Based Chemotherapy (TroFuse-021/ENGOT-ov85/GOG-3102)
Ovarian
Ovarian
Ovarian
III
Brown, Alaina
NCT07318558
VICC-DTGYN24082
A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors
Miscellaneous
Miscellaneous
Miscellaneous
I/II
Cardin, Dana
NCT04657068
VICCGIP25035
A Phase 1, Open-Label, Multicenter Study of INCA033989 Administered as a Monotherapy or in Combination with Ruxolitinib in Participants with Myeloproliferative Neoplasms
Leukemia
Leukemia
Leukemia
I
Mohan, Sanjay
NCT06034002
VICC-DTHEM23416P
Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE Study)
Hematologic
Hematologic
Hematologic
III
Dholaria, Bhagirathbhai
NCT03394365
VICCCTT1875
An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
Multiple Cancer Types
Neuroblastoma (Pediatrics),
Pediatric Solid Tumors
N/A
Kitko, Carrie
NCT01590680
VICCPED1249
NRG-CC015: Harnessing E-Mindfulness Approaches for Living-After Breast Cancer---HEAL-ABC
Breast
Breast
Breast
III
Kennedy, Laura
NCT06748222
NRGBRECC015
A Phase 2 Dose Optimization Trial Evaluating a CD46-Targeted Antibody-Drug Conjugate (FG-3246) in Patients with Metastatic Castration-Resistant Prostate Cancer
Prostate
Prostate
Prostate
II
Schaffer, Kerry
NCT06842498
VICCURO24538
A Phase II/III, Multisite, Randomized Master Protocol for a Global Trial of BNT327 in Combination with Chemotherapy and Other Investigational Agents in First-Line Non-Small Cell Lung Cancer
Lung
Lung
Lung
II/III
Shanshal, Mohamed
NCT06712316
VICC-DTTHO24159
Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Patients with Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
N/A
Oluwole, Olalekan
NCT05346835
VICC-XDCTT24033
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Multiple Cancer Types
Germ Cell (Pediatrics),
Gynecologic,
Ovarian
III
Borinstein, Scott
NCT03067181
COGAGCT1531
